A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. (Q51824419)
Jump to navigation
Jump to search
scientific article published on 12 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. |
scientific article published on 12 February 2009 |
Statements
A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. (English)
1 reference
L Tan
1 reference
G Atkinson
1 reference
J Ward
1 reference
UK-500,001 Global Study Team
1 reference
12 February 2009
1 reference
33
1 reference
5
1 reference
1039-1044
1 reference